{"id": 1, "score": 2.89, "relevant": "No", "text": "Cycloserine inhibits the two enzymes that pentapeptide side chain on N-acetylmuramic acid cannot be made (see Fig.", "common_words": 2, "features": [0.22, 0.0, 0, 1, 0.67, 0.22]}
{"id": 2, "score": 2.85, "relevant": "No", "text": "The mechanism of resistance is very different for vancomycin and penicillin, which makes vancomycin particularly useful against penicillin-resistant bacteria.", "common_words": 3, "features": [0.3, 0.0, 0, 1, 0.6, 0.1]}
{"id": 3, "score": 2.6, "relevant": "No", "text": "To prevent the development and spread of vancomycin-resistant bacteria, this antibiotic is typically used only as a drug of last resort.", "common_words": 2, "features": [0.2, 0.0, 0, 1, 0.6, 0.0]}
{"id": 4, "score": 2.5, "relevant": "No", "text": "Normally, bacitracin is used only topically because of serious side effects, such as kidney damage, which can occur if bacitracin is ingested.", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.75, 0.0]}
{"id": 5, "score": 2.36, "relevant": "No", "text": "Bacitracin binds to and inhibits dephosphorylation of the carrier, thereby preventing the to bacitracin can develop if the organism can rapidly recycle the phosphorylated lipid carrier molecule through dephosphorylation or if the organism possesses an efficient drug export system (discussed in Section 27.3).", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.67, 0.05]}
{"id": 6, "score": 2.36, "relevant": "No", "text": "However, the antibiotic teixobactin, discussed in and stop growth of vancomycin-resistant Gram-positive Note that antibiotics targeting cell wall biosynthesis generally kill only growing cells.", "common_words": 3, "features": [0.18, 0.0, 0, 1, 0.47, 0.12]}
{"id": 7, "score": 1.72, "relevant": "No", "text": "Vancomycin, a very large and complex glycopeptide produced by the streptomycete Amycolatopsis orientalis the disaccharide unit and prevents the action of transglycosylases and transpeptidases (see Fig. 27.7).", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.31, 0.19]}
{"id": 8, "score": 1.6, "relevant": "No", "text": "These drugs do not affect static or stationary-phase cells, because in this state the cell has no need for new peptidoglycan.", "common_words": 1, "features": [0.1, 0.0, 0, 0, 0.7, 0.0]}
{"id": 9, "score": 0.0, "relevant": "No", "text": "Another enzyme in the functions just fine, but the organism is resistant to the form.", "common_words": 2, "features": [0.33, 0.0, 0, 1, 0.67, 0.0]}
{"id": 10, "score": 0.0, "relevant": "No", "text": "Resistance to vancomycin can develop when products which vancomycin cannot bind.", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.4, 0.4]}
{"id": 11, "score": 0.0, "relevant": "No", "text": "Without these alanines, cross-linking cannot occur and peptidoglycan integrity is compromised.", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.57, 0.0]}
{"id": 12, "score": 0.0, "relevant": "No", "text": "27.7).", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.0, 0.0]}
{"id": 13, "score": 0.0, "relevant": "No", "text": "Relative to bacitracin, it acts at an even earlier step in peptidoglycan synthesis.", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.43, 0.0]}
{"id": 14, "score": 0.0, "relevant": "No", "text": "growing chain (see Fig. 27.7).", "common_words": 0, "features": [0.0, 0.0, 0, 1, 0.25, 0.25]}
